J&J Recalls Tylenol Products Amid Odor Concerns

Law360, New York (March 29, 2011, 7:36 PM EDT) -- A Johnson & Johnson unit recalled one lot of Tylenol extended release caplets Tuesday after complaints of a musty odor and expanded another recall of over-the-counter drugs produced at a Pennsylvania plant that is no longer manufacturing drugs.

McNeil Consumer Healthcare, part of J&J's McNeil-PPC Inc., voluntarily recalled one lot of Tylenol eight-hour extended-release caplets in 150-count bottles as part of the company's ongoing efforts to monitor products for musty or moldy odors that are thought to be caused by the chemicals 2,4,6-tribromoanisole and 2,4,6-trichloroanisole....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.